There are 2789 resources available
1538P - Germline testing of sarcoma revealed frequent mutations in genes involved in DNA repair, RNA metabolism, and epigenetic regulation
Presenter: Haicheng Gao
Session: ePoster Display
1539P - Sarcomas in the Dutch LFS population: Data from the national screening of TP53 germline mutation carriers at the Netherlands Cancer Institute
Presenter: Gijsbrecht de Wit
Session: ePoster Display
1540P - Ripretinib as ≥4th-line treatment in patients with advanced gastrointestinal stromal tumor: Long-term update from the phase III INVICTUS study
Presenter: Margaret von Mehren
Session: ePoster Display
1541P - Real-world data from patients with gastrointestinal stromal tumors (GIST) treated in Dutch GIST expertise centers
Presenter: Nikki IJzerman
Session: ePoster Display
1478P - Trends in treatment patterns among Medicare fee-for-service (FFS) patients receiving treatment for metastatic pancreatic cancer
Presenter: Gabriela Dieguez
Session: ePoster Display
1479P - Exploring second-line therapy outcome in pancreatic ductal adenocarcinoma (PDAC) patients with germlineBRCA1-2 pathogenic variants (gBRCA1-2pv)
Presenter: Giulia Orsi
Session: ePoster Display
1378P - A single-center, prospective, open-label, single-arm trial of sintilimab with paclitaxel and carboplatin as a neoadjuvant therapy for esophageal squamous carcinoma
Presenter: Zhi Zhang
Session: ePoster Display
1379P - Margetuximab (M) with retifanlimab (R) in HER2+, PD-L1+ 1st-line unresectable/metastatic gastroesophageal adenocarcinoma (GEA): MAHOGANY cohort A
Presenter: Daniel Catenacci
Session: ePoster Display